Jul 3, 2024, 17:29
Benjamin Besse: Stop pembro after 2 years?
Benjamin Besse, Head of Clinical Research at Gustave Roussy, shared on X:
“Stop pembro after 2 years? In 43,359 pts that received up-front pembrolizumab for an advanced NSCLC, continuation beyond 2 years was not associated with better OS than a fixed 2-year treatment, HR = 0.97 [0.75–1.26] p = 0.95.”
Source: Benjamin Besse/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 18, 2024, 23:03
Sep 18, 2024, 22:46
Sep 18, 2024, 21:59
Sep 18, 2024, 17:34
Sep 18, 2024, 16:43
Sep 18, 2024, 16:38